Prevention of food allergy and atopic disease
Robert S Zeiger MD PhD SECTION OF PAEDIATRICS, 22 OCTOBER 1996 OVERVIEW OF ALLERGY PREVENTION Food allergy, with a prevalence of 4-6% in childhood, represents a major and potentially life-threatening burden to our children. Studies on the natural history of food allergy document that clinical allergy to foodstuffs such as milk, egg and soy frequently remit while allergy to peanut, nuts, and fish typically persists during childhood. Avoidance of foodstuffs after sensitization and food allergy development appear to hasten tolerance; however, the mechanism for the development of clinical tolerance to one group of food allergens and not another is poorly understood.
An urgency exists today to identify and develop effective strategies to prevent food allergy and other allergic afflictions owing to their epidemic worldwide increase in prevalence and morbidity. Though genetic, and particularly immunological, engineering hold promise for food allergy and atopy prevention, environmental strategies which promote food allergen and aeroallergen avoidance provide an avenue for prevention at the present time. These latter efforts rely on active efforts to reduce the allergenic load and exposure of atopic-prone infants and children to allergenic foodstuffs and aeroallergens. Moreover, allergy prevention can be directed at three potential stages of allergic sensitization and disease manifestation including: (1) primary prevention which inhibits IgE and other immunological sensitization; (2) secondary prevention which abrogates disease expression subsequent to immunological sensitization; and (3) tertiary prevention which suppresses symptoms after and despite disease expression1. Strategies to promote allergen avoidance have met with great difficulty at all of these stages due to limitations in knowledge, societal compliance and resources. Though primary prevention of allergy is optimal, secondary prevention may be a necessary adjunct to the former or serve as a fall-back option to families uninterested in allergy prevention until real markers of atopic risk are identified in their offspring. Tertiary prevention, the arena most familiar to practising allergists and paediatricians, is generally instituted after manifestations of allergy are recognized, often long after clinical disease has been expressed and suffering experienced. These stages must be integrated into any programme to prevent the consequences of atopic disease. The success of allergen prevention strategies must be judged by the degree to which they satisfy specific criteria including the ability to: (1) predict the high-risk infant and child; (2) demonstrate effectiveness of the intervention strategy; (3) utilize acceptable interventions; (4) minimize adverse effects; and (5) generate cost effective outcomes. To date, no allergen avoidance intervention study has met all of these requisites.
A critical period appears to exist early postnatally in which the genetically programmed atopic-prone infant may be at an increased risk to become sensitized to exposed/ encountered allergens. Prompt perinatal identification of such at-risk neonates would be important should preventive efforts prove efficacious, safe and cost-effective. Many genetic linkage markers2 and immunological factors/ markers (elevated cord blood and infancy IgE levels, egg specific-IgE, lower gamma-interferon/IL-4 ratio, etc.) have been determined to be significantly associated with the subsequent development of allergic disease; however, none possesses greater sensitivity or specificity than atopic family history for the practical screening of at risk neonates for primary allergy prevention3.
With respect to the institution of anti-allergy measures, certain major atopic risk factors such as atopic heredity, male gender and non-white ethnicity are not modulatable, while other factors such as birth month, low socioeconomic status, and urban residences are poorly modulatable. Possible ways to modulate atopic risk factors include (1) raising low atopic health consciousness; (2) delaying introduction of allergenic foods during infancy; (3) reducing household dust mite, cockroach and dander levels; and (4) reducing environmental pollution and environmental tobacco exposure (ETS). Table 1 presents a strategy for both the identification of high-risk infants and institution of preventive measures directed at all three stages of allergy prevention4.
PRIMARY PREVENTION OF ALLERGY (Table 2) More than 60 years ago Grulee and Sanford reported that eczema was reduced sevenfold by breast-feeding compared to cow's milk feeding in a cohort of nearly 20 000 infants5. Disparate studies have followed. The failure to appreciate and account for the many routes of food exposure may be responsible for these studies' disparate findings. Chicken's egg, cow's milk, peanut, fish, nuts and soy represent those ETS=environmental tobacco smoke foods in the USA most likely to induce food specific-IgE (sensitization) in infancy and childhood. The newborn potentially may become exposed to these and other food allergens through such routes as the placenta, breast milk, formula, solid food, and even inadvertently through airborne droplets or floor dusts.
Avoidance of allergenic foods during pregnancy
The immunological response of the fetus to foods and other allergens requires further study but the fetus does seem occassionally to mount specific IgE responses to foods6'7 and frequently T cell responses to milk and egg proteins and aeroallergens8. The real extent and importance of these responses need elucidation. Present evidence against the importance or frequency of specific-IgE food sensitization in utero emanates from food allergen avoidance studies initiated during pregnancy. These investigations clearly demonstrated that food allergen avoidance during pregnancy did not affect the development of atopy in infancy9-13.
Specifically, two randomized studies compared third trimester pregnancy maternal diets devoid of milk and egg or with limited ingestion of milk or egg to either normal or high exposure to these foods9-13. Both avoidance regimens prenatally failed to reduce the development of atopy in high-risk infants maintained on a hypoallergenic feeding regimen postnatally ( Table 2 ). Cow's milk and egg avoidance prenatally failed to alter cord blood IgE levels, the incidence of food sensitization, or the development of atopic diseases at 6 to 60 months9-13. These negative findings combined with the potential for harmful nutritional effects of such diets on mother and fetus9'14 indicate that such food avoidance regimens during pregnancy should not be recommended.
Breast-feeding
Breast milk feeding represents the ideal nutritional, immunological, physiological and psychological environment for the newborn. As such, breast-feeding should be encouraged in all neonates, including those with atopic risk, even though small quantities of food allergens may be present in breast milk.
Protective effect of breast milk on allergen exposure and absorption Breast milk inhibits the increase in food antigen absorption which occurs early postnatally in newborn animals1s. In 
humans, significantly higher antigen absorption occurs in preterm than in term neonates16; hence, preterm or low birth weight infants are at greater risk of developing IgE sensitization to foods, particularly cow's milk formula. An uncontrolled retrospective study reported that total sIgA and milk-specific IgA antibodies to whole cow's milk and casein were significantly lower in breast milk from mothers of allergic compared to non-allergic infants17; however, two prospective studies failed to demonstrate any protective effect of breast milk specific antibodies on infant sensitization2'18.
Breast versus cow's milk feeding on allergic sensitization and allergic disease Debate, begun over 60 years ago, continues regarding the degree to which breast-feeding prevents, reduces, delays, or increases the development of allergic disease1'3 1926* Differences in study design, quality, size and duration of breast-feeding may account for this disparity. Several comprehensive reviews give perspective to this subject3'27.
Although the sheer number of published studies supports the benefits of breast-feeding in reducing allergic disease development when compared to cow's milk formula feeding, several prolonged exclusive breast-feeding investigations of atopic-prone infants failed to demonstrate any allergy protective role of breast-feedingl3'27. These investigations may have been fatally compromised by the failure to randomize the study groups, with consequent recruitment biases, incomparable groups, and unknown confounding variables. For example, mothers who breastfeed tend to smoke less, attain higher parental educational level, and delay day care-behaviours which might be expected to reduce atopic risk factors such as introducing solid food early, exposing infants to viruses, and reducing second-hand smoke inhalationl. In addition to not randomizing groups, these breast versus cow's milk comparison studies were individually flawed by such shortcomings as (1) non-blinded evaluations; (2) absence of immunological confirmation of diagnoses; (3) failure to document compliance; (4) inadequate sample size; (5) brief duration of breast-feeding; and (6) differences in environmental control measures between groups. A 17-year follow-up of a non-randomized study suggested that prolonged exclusive breast-feeding for at least 6 months compared to cow's milk feeding provides a long-term allergy protective effect on the development of respiratory allergy during adolescence26. The conclusion must be tempered by the study's failure to randomize groups, provide any group demographic data, and compare aeroallergen sensitization between groups. The one prospective randomized study comparing human milk with cow's milk on the development of atopy examined a preterm infant cohort28. This prospective, demonstrated that early exposure to cow's milk formula compared to banked breast milk increased the risk of developing allergic disease by 18 months (particularly eczema) (odds ratio 3.6 with 95% confidence interval 1.4-9.1) in only the subgroup of neonates with an allergic family history28. IgE-sensitization or food allergy was not investigated.
Such design limitations preclude definitive conclusions regarding the potential benefits of breast-feeding in reducing allergic disease. The detection of dietary allergens in breast milkl and the early sensitization of exclusively breast-fed infants to egg and milk29 add complexity to this situation. These findings indicate that institution of maternal dietary restrictions during exclusive breast-feeding might be necessary to prevent food allergy. Notwithstanding the above, prolonged breast-feeding promotion for infants must be promoted for its nutritional, immunological, intestinal and psychological benefits. Whether breast-feeding prevents food and other atopic disorders remains to be settled, but the weight of evidence supports a protective effect.
Maternal avoidance of allergenic food during lactation Food allergens in human breast milk have been implicated in the development of food-specific IgE sensitization and food allergy in up to 6% of high-risk infants who are exclusively breast-fed, with symptom onset occurring with the reported initial direct food exposure2'30. Moreover, milk-specific IgE has been reported commonly in and even sometimes more often in breast-fed than in formula-fed infants31. Food allergens in breast milk may be responsible for this phenomenon. Thus far three bovine milk antigens (fl-lactoglobulin (BLG), casein and gammaglobulin)32-35 chicken's egg ovalbumin (OVA)36, and gliadin37 have been detected in nanogram concentrations in most samples of breast milk from mothers within 2-6 h of consuming these foods. Molecular size analyses suggest that these food antigens maintain their potential for infant sensitization38'39. It has yet to be proven definitively whether such quantities and size offood allergens in breast milk can prime an infant to IgE sensitization.
Recognition of potentially allergenic food antigens in breast milk led to attempts to evaluate the effect of maternal food allergen avoidance diets during lactation on the development of atopy ( Table 2 )40-44. Two prospective controlled studies4044, one ofwhich was truly randomized44, evaluated whether maternal avoidance of egg, cow's milk and fish for the first 3 months of lactation4>42 or avoidance of those foods plus soy and peanut avoidance for the entire lactation period compared to unrestricted maternal diets affected atopy in high-risk infants placed on a relatively hypoallergenic dietary regimen during infancy ( Table 2) . Both studies noted significant reductions in eczema in the maternal diet groups by 3 and 6 months40'41, 18 months4 but randomized, and controlled study of preterm neonates not by 10 years43. A recent non-randomized nested casecontrol study from Southampton, UK, reported in abstract form, quite disparate results regarding the effects of maternal lactation food allergen avoidance diets45'46. In this study, infants from dieting mothers developed significantly more eczema and food sensitization from 6 to 18 months of age. Unexplained was the higher prevalence of aeroallergen sensitization in the non-lactation diet group46. Whether lack of randomization and confounding remains responsible for these differences will only be resolved by a definitive prospective, randomized multicentre lactation diet study. Maternal lactation allergen avoidance diets must be considered experimental at this time.
Effect of soy feeding on development of atopy Initial retrospective studies47-49 extolled the value of soy formula feeding in reducing atopy. Subsequent randomized prospective studies of infants, generally from atopic families, uniformly failed to demonstrate any reduction in the development of atopy in infancy and childhood derived from soy compared to cow's milk feeding5S 53. These findings are consistent with studies that verified the immunogenic and allergenic capacity of soybean protein54.
These results suggest that intact soybean protein formulas should not be employed for primary allergy prophylaxis.
Hypoallergenic protein hydrolysate formulas on development of allergic disease Immunogencity and allergenicity Protein hydrolysates (PH) reveal different biological and immunological characteristics depending in part upon the extensiveness of hydrolysis and ultrafiltration. The two casein hydrolysates, Nutramigen and Alimentum, represent extensively hydrolysed formulations5S5'6 which are hypoallergenic as defined by the American Academy of Pediatrics (95% confidence that at least 90% of cow's milk-allergic children will tolerate the PH formula) by double-blind placebo-controlled food challenges (DBPCFC), the gold standard in food testing. In contrast, the whey hydrolysate, Good Start, is (1) only partially hydrolysed; (2) contains at least 20% of peptides of large molecular weight (>4000 daltons); (3) possesses more than 2 logs higher levels of immunologically identifiable cow's milk proteins than either of the casein hydrolysates; and (4) induces allergic reactions in at least 50% of infants with cow's milk allergyS5-58. The casein hydrolysates have received hypoallergenic labelling and the safety and hypoallergenicity of Nutramigen has been documented in more than 50 years of safe commercial use in milk-sensitive infants and children1; although, they are not completely non-allergenic since in rare instances they have caused allergic reactions59 or intolerances60 in cow's PH formula (Profylac), unavailable in the USA, has also recently been shown to be hypoallergenic.)61 It remains prudent, therefore, to introduce these extensively hydrolysed PH for the first time in cow's milk allergic patients under the direct supervision of physicians experienced and equipped to treat anaphylaxis. These findings should dissuade clinicians from using partially hydrolysed milk protein formulas in cow's milk-allergic patients1 '56 Prevention of atopy When breast-feeding is rejected, formulae with the least immunogenic and allergenic potential should be fed to high-risk infants in the attempt to prevent food allergy. Extensive PH (as part of a hypoallergenic dietary regimen) compared to cow's milk feeding from birth in non-breast-fed infants or as a supplement to breast-feeding was associated with a lower prevalence of formula allergy and specific-milk IgE by one year in infants at-risk for atopy14. In addition, the hypoimmunogenicity of the extensive PH was documented by its capacity compared to cow's milk formula to inhibit the IgG BLG response prior to and following cow's milk introduction62.
Comfirming the above, two prospective, randomized controlled studies in non-breast-fed atopic-prone infants demonstrated that an extensively hydrolysed casein44 and partially hydrolysed whey53'63 hydrolysate, compared to cow s milk or soy feeding, were associated with a lower cumulative incidence of eczema in infancy4453'63 ( Table 2 ). Immunological and food challenge confirmation was omitted4 or incomplete53'63 in these studies. Though several other studies have attempted to determine the effectiveness of PH in allergy prevention6"6 none have proven definitive, owing to design weaknesses ( Table 2) .
These studies require confirmation with a definitive prospective, randomized, masked, food challenged study which determines whether PH prevent cow's milk allergy before PH are proclaimed effective and safe for the prevention of atopy in high-atopic risk infants when breastfeeding is not a choice or formula supplementation is desired. Extensive hydrolysates are hypoallergenic and hypoimmunogenic while the partial whey hydrolysates may induce milkspecific IgE and are more likely to cause anaphylaxis in an infant who has become sensitized to cow's milk from other sources. The European Society of Paediatric Allergy and Clinical Immunology has recommended that the extensively hydrolysed hypoallergenic PH may be the preferred choice compared to the partial whey PH for purposes of allergy prevention until more definitive studies are published56.
Delayed introduction of solid foods
The effect of solid foods on eczema up to ages 2 and 10 years and on asthma up to age 4 years was analysed in an milk sensitive subjects. (An extensively hydrolysed whey S u p p eme nt N o 30 Vo u me 90 1 9 9 7 unselected, uncontrolled, prospective birth cohort study of 1265 New Zealand neonates in which 84% were evaluated at 10 years67'68. Eczema prevalence was associated significantly with parental atopy and solid feeding patterns. In contrast, the development of asthma was unrelated to solid food feeding69. A statistically significant linear relationship existed between the number of solid foods introduced during the first 4 months of life and the subsequent development of eczema by 23 years67 and recurrent/chronic eczema by 10 years68. This series of reports were chart reviews and did not include immunological or food challenge data.
Eczema at 1 year (14% versus 35%, P<0.01), but not at ages 3, 5, 10 or 17 years, was reduced in infants exclusively breast-fed for 6 months compared to a group of breast-fed infants in whom solid foods were introduced at 3 months of age in a prospective non-randomized study of high-risk newborns26'70'71. Lack of randomization weakens the impact of this study.
Such findings suggest that early exposure to multiple foodstuffs may predispose infants, particularly those at risk for atopy, to recurrent or chronic eczema. Solid food avoidance until after 6 months in the high-risk infant has many advocates; definitive studies would justify such pronouncements.
Maternal and infant avoidance of allergenic foods in high-risk offspring
Since the infant is exposed to foods from multiple sources (placenta, breast, formula, and solid foods), two prospective, randomized, controlled studies from Canada72 and the USA14'62'73'74 implemented diverse maternal and infant food allergen avoidance interventions. These studies were initiated prior to publication of studies that failed to demonstrate any allergy preventive effect from food allergen avoidance during the third trimester of pregnancy (Table 2)9-13. Be reminded that multiple intervention studies are unable to identify the factors/interventions most responsible for observed effects.
Maternal avoidance diet throughout pregnancy and lactation with 6 months exclusive breast-feeding A significantly reduced severity and marginally reduced incidence of eczema by 1 year occurred when mothers excluded milk, egg, peanut, fish and beef throughout pregnancy and lactation compared to a group whose mothers maintained an unrestricted diet ( Combined maternal and infant food allergen avoidance during the perinatal period on atopy from birth to 7 years in high-risk offspring In a prenatally randomized, physician-blinded, parallel-born to documented allergic parents, the effect of combined maternal and infant food allergen avoidance (prophylaxis group) was compared to currently recommended maternal and infant feeding practices on the development of allergic disease from birth to 7 years. This study found that, compared to controls, prophylaxis infants exhibited significantly (1) lower prevalances of atopic disorders, including atopic dermatitis at 1 year, due to lower prevalences of food allergy; and (2) reduced specific IgE and IgG sensitization to cow's milk up to 2 years of age. Allergic rhinitis, asthma and aeroallergen sensitization to mite, dander, mould, and pollen from birth to 7 years were unaffected by the dietary interventions14'62.
It appears from these studies that strict prolonged food avoidance perinatally by mother and infant for more than 6 months reduces the development of food allergy during early infancy, but not allergic respiratory disorders. Food allergy prevention may be brief and limited to the first year or two of life due to the frequent remissions in food allergy and the elimination of the responsible foods from the diets of food allergic infants. The above benefits from combined maternal and infant avoidance regimens are probably not due to the intervention during pregnancy, since prenatal maternal dietary restrictions, when examined separately in prospective randomized studies, fail to prevent food allergy in infancy9-1 3. The relative benefits of the other interventions can only be speculated upon and unravelled by future studies.
Combined maternal and infant food allergen avoidance postnatally and household mite avoidance Expanding upon the above, the group from the Isle of Wight added a household dust mite avoidance regimen (mite retardant pillow and mattress zippered encasements and acaricide treatments of household furnishings and carpeting) to combined postnatal maternal and infant food allergen avoidance protocols in the primary prevention of food and respiratory allergic disease75'76. This prospective, randomized, controlled study in high-risk infants noted that the combined food allergen and dust mite avoidance regimen in early infancy led to a significant reduction in any atopy, eczema and asthma at 1 year75 and atopy and food and/or aeroallergen sensitization by 2 years (Table 2) 76.
Mite levels were lower significantly in the prophylaxis group only at 9 months. Unrestricted infancy diet, parental smoking, maternal atopy, and lower socio-economic status were risks for the development of atopy. At the present time, this is the first primary prevention study directed at respiratory allergy and requires confirmation. controlled multiple food allergen avoidance trial on infants Caution, implications and recommendations for primary prevention Uncertainty remains regarding the degree of benefit attainable by dietary and aeroallergen intervention, despite the flourish of prospective, controlled and randomized primary allergy prevention studies. Needed are well-designed, masked, multicentre primary prevention trials with clearly defined single interventions that determine the development of atopic disorders by precise clinical and immunological criteria. Therefore, at the present time only provisional recommendations can be offered for primary allergy prevention and should be directed at high-risk offspring with highly motivated parents and should not be recommended universally (Table 3 ).
SECONDARY PREVENTION OF ALLERGY
Secondary prevention may be a useful adjunct to or alternative for families who need stronger and more immediate evidence of atopic risk before pursuing allergy prevention measures. Effective primary and tertiary allergy prevention strategies could be utilized.
Prediction of the high-risk atopic postnatally
The rationale for secondary allergy prevention derives from the natural history of allergy which progresses relentlessly in an 'atopic march' pattern. The 'atopic march' signifies that certain atopic conditions or events often precede the development of other more permanent atopic disorders. This can be gleaned from the following situations: food allergy and food and inhalant sensitization precede allergic rhinitis and atopic asthma77-80; atopic dermatitis precedes atopic asthma81-83; infectious asthma with concomitant elevated IgE in infancy precede asthma84; peripheral blood eosinophilia at 3 months of age85 or nasal eosinophils at age 1 year precede allergic rhinitis75. Based on the 'atopic march', high-risk infants could be identified for the purposes of instituting secondary allergy prevention after the onset of one of the following: (1) an indicator atopic marker (specific food (egg, milk, or peanut)-IgE, aeroallergen-IgE, elevated serum IgE, or blood or nasal eosinophilia); and/or (2) an indicator atopic disorder (food allergy, atopic dermatitis, or infectious asthma and elevated serum IgE). A documented or strong parental history of allergies, particularly on the maternal side (maternal asthma) given its predictive capacity for atopy and asthma, could also be used. An approach to secondary allergy prevention A potentially efficient and cost-effective approach to allergy prevention could involve periodic prospective surveillance of infants (young children) for the clinical and immunological expression of atopic sensitization (markers) or disease. The high-risk infant during well-baby visits could be identified by the primary health-care provider by ascertaining (1) atopic sensitization by performing skin prick tests or Pharmacia CAP ELISAs to foods such as egg and milk twice during infancy (4 and 12 months) and yearly to aeroallergens such as dust mite, mould mixes, cat (or dog), and grass mixes beginning at age 1 year; and (2) atopic disease expression by recognizing recurrent infectious wheezing with elevated serum IgE levels, eczema and food allergy. These identified high-risk infants could then be referred to allergy specialists for allergy prevention interventions. Studies are necessary to determine the feasibility of such a secondary allergy prevention programme. noted above. Aeroallergen, ETS, and pollution avoidance could be instituted. Additionally, pharmacological/immunological modulation might be instituted. Recently ketotifen was reported in two randomized double-blind placebo-controlled studies to reduce by more than 60% the onset of asthma over the subsequent 1286 or 36 months87 in non-asthmatic high-risk infants with elevated serum IgE levels and either atopic dermatitis86 or an immediate family history of asthma87. Neither serum IgE levels86 nor aeroallergen sensitivity by skin test87 were affected by ketotifen, suggesting that symptoms rather than allergic sensitization may have been affected. An important European multi-country study (Early Treatment of the Atopic Child (ETAC)) is evaluating the role of cetirizine in the secondary prevention of asthma. The use of immunotherapy for allergic rhinitis in children has been recommended88, but not proven to prevent the progression of allergic rhinitis to allergic asthma. Current investigations in Europe on the role of immunomodulation in secondary allergy prevention are underway.
Advantages and disadvantages of primary and secondary allergy prevention Primary and secondary allergy prevention possess relative advantages and disadvantages as summarized in Table 4 . Each stage complements the other and all may need to be instituted to reverse the worldwide increase in allergic disease.
TERTIARY ALLERGY PREVENTION
All too often mere lip service rather than detailed advice and support is given to patients, and families are left on Role of the generalist Generalists, whether paediatricians or primary care providers, represent the first link in tertiary allergy prevention, in that they represent the first line of caregivers able to recognize and diagnose atopy. Early and accurate diagnosis provides the opportunity for early institution of preventive strategies. Generalists should link themselves to allergy specialists who can deliver preventive allergy advice and care to families of newly diagnosed atopic infants and children.
Role of the allergy specialist By specializing in the diagnosis, treatment and prevention of food allergy, eczema, allergic rhinitis, asthma, venom hypersensitivity and anaphylaxis, allergists must assist generalists in the confirmation or diagnosis of referred atopic children; provision of comprehensive guidelines on allergen, irritant and adjuvant avoidance measures to families of the atopic; and dissemination to the generalist and family of recent advances in allergy prevention. Allergy prevention guidelines should include measures to delay the introduction of allergenic foods; reduce mite, dander and animal emanations in the home; decrease mould and pollen exposure; promote smoking cessation and ETS avoidance; encourage safe occupations and occupation safety; and reduce air pollution contact ( Table 5 ). The allergist should deliver appropriate preventive pharmacological interventions for atopic disease according to recent national and international recommendations89.
FUTURE OF ALLERGY PREVENTION
We are approaching an exciting era in allergy prevention in which novel, effective and safe immunomodulatory therapies will be part of the allergists' arsenal. We should be lobbying for an increased international consciousness for allergy awareness and prevention that will be primed when such breakthroughs occur (Table 6 ). For the present time, in addition to the above proposed allergy prevention recommendations, some help from the friendly gods would not hurt. In the interim, an 'Allergy Prevention Bill of Rights' could be promulgated to protect families from the consequences of atopic disease. Such rights would espouse the right to be breastnot formula-fed, the right to live in dust-miteless homes, the right to be free from indoor pets, the right to be free from ETS, the right to breathe clean air, and the right to be screened for/advised of allergy 
IMPLICATIONS AND RECOMMENDATIONS FOR THE PREVENTION OF ATOPY
The above discussion highlights the need for more definitive data before international allergy prevention recommendations are developed. Randomized, prospective, controlled multicentre studies, if possible doubleblind, should determine the relative efficacy, practicality, and cost of implementing allergy preventive measures including protein hydrolysate feeding, maternal lactation diet, and the delay in introduction of allergenic foods in the attempt to reduce food allergy. In addition, similarly well-designed studies should determine whether elimination of environmental pollutants (parental smoking preand post-partum) and aeroallergens such as dust mite and danders (postnatally) will affect such atopic disorders as asthma, allergic rhinitis and atopic dermatitis. Obstacles to the success of these preventive efforts include parental compliance, motivation 
